Global Engineered T Cells Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 46.5% - ResearchAndMarkets.com

DUBLIN--()--The "Engineered T Cells Market by Type, Application and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global engineered T cells market was valued at $145.97 million in 2016, and is estimated to reach at $2,124.02 million by 2023, registering a CAGR of 46.5% from 2017 to 2023.

T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient's body to reduce toxicity levels and restrict antigen escape for elimination of cancerous cells.

Increase in of incidence of various types of cancers and autoimmune diseases is projected to drive the growth of the engineered T cells market. In addition, advantages offered by engineered T cells therapies over traditional cancer treatments such as chemotherapy, high technological advancements, and increase access to medical insurance are expected to boost the market growth.

The engineered T cells market is segmented based on type, application, end user, and geography. On the basis of type, the market is categorized into chimeric antigen receptor (CAR) modified T cells, tumor infiltrating lymphocytes (TIL), and T cells receptor (TCR) modified T cells. By application, it is classified into lung cancer, breast cancer, colorectal cancer, melanoma, leukemia, and other applications. Depending on end user, it is fragmented into hospitals, cancer research centers, and clinics.

Companies Mentioned:

  • Autolus Limited
  • Bellicum Pharmaceuticals, Inc.
  • Cell Medica
  • Elli Lilly and Company
  • Gilead Sciences, Inc.
  • Juno Therapeutics
  • Novartis AG
  • Oxford Biomedica
  • Pfizer Inc.
  • Precision Bioscience

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Engineered T Cells Market, By Type

Chapter 5 Engineered T Cells Market, By Application

Chapter 6 Engineered T Cells Market, By End User

Chapter 7 Engineered T Cells Market, By Region

Chapter 8 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/3fcjvs/global_engineered?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Engineering

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Engineering